Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.2113
H.R.2113: Prescription Drug STAR Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced April 8, 2019
- Latest Major Action Dec. 24, 2020
Bill Sponsor
Bill Cosponsors
12 (10 Democrats, 2 Republicans)
Bill Version
- Introduced in House - April 8, 2019
Bill Summary
Prescription Drug Sunshine, Transparency, Accountability and Reporting Act or the Prescription Drug STAR Act This bill establishes requirements for prescription drug manufacturers to provide certain information about pricing, discounts, and product samples of applicable drugs. Specifically, the bill requires the Department of Health and Human Services (HHS) to annually determine whether there are price increases of a certain threshold for...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Congressional Budget Office Estimate
Bill Actions
Date | Description |
---|---|
Dec. 24, 2020 |
Placed on the Union Calendar, Calendar No. 571.
|
Dec. 24, 2020 |
Committee on Energy and Commerce discharged. |
Dec. 24, 2020 |
Reported (Amended) by the Committee on Ways and Means. H. Rept. 116-688, Part I.
|
April 9, 2019 |
Ordered to be Reported by Voice Vote.
|
April 9, 2019 |
Committee Consideration and Mark-up Session Held.
|
April 9, 2019 |
Referred to the Subcommittee on Health.
|
April 8, 2019 |
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
|
April 8, 2019 |
Referred to the Subcommittee on Health.
|
April 8, 2019 |
Introduced in the House by Richard E. Neal (D-Mass.) |